BRIEF-Amylyx Pharmaceuticals Q1 EPS USD -0.42 Vs. IBES Estimate USD -0.47

Reuters
08 May
BRIEF-<a href="https://laohu8.com/S/AMLX">Amylyx Pharmaceuticals</a> Q1 EPS USD -0.42 Vs. IBES Estimate USD -0.47

May 08 (Reuters) - Amylyx Pharmaceuticals Q1 operating expenses USD 37.803 million.

  • Q1 operating income USD -37.803 million vs. IBES estimate USD -41.1 million
  • Q1 pretax profit USD -35.907 million
  • Q1 net income USD -35.907 million vs. IBES estimate USD -38.5 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10